Schedule 13D ownership disclosure

CB Pharma Acquisition Corp.

Security class unavailable · CUSIP: G2029P126

Event date: 2014-12-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
23.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-15-000017
Form type
SC 13D
Filer
Origo Acquisition Corp
CIK
CIK 1619551
Filed
Jan 05, 2015
Reporting period
Dec 17, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub